Beam Therapeutics Ownership | Who Owns Beam Therapeutics?
Beam Therapeutics Ownership Summary
Beam Therapeutics is owned by 16.97% institutional investors, 1.23% insiders, and 81.80% retail investors. Ark investment management is the largest institutional shareholder, holding 12.27% of BEAM shares. ARK Disruptive Innovation Full Composite is the top mutual fund, with 8.26% of its assets in Beam Therapeutics shares.
BEAM Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Beam Therapeutics | 16.97% | 1.23% | 81.80% |
| Sector | Healthcare Stocks | 232.86% | 10.65% | -143.51% |
| Industry | Biotech Stocks | 382.13% | 10.41% | -292.54% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ark investment management | 12.13M | 12.27% | $289.14M |
| Fmr | 11.69M | 11.46% | $283.79M |
| Farallon capital management | 10.06M | 9.87% | $244.23M |
| Blackrock | 7.63M | 9.34% | $178.87M |
| Vanguard group | 9.19M | 8.96% | $254.84M |
| Blackrock funding, inc. /de | 8.49M | 8.58% | $202.26M |
| Arch venture management | 4.54M | 4.45% | $110.19M |
| State street | 4.01M | 3.93% | $97.29M |
| Sumitomo mitsui trust | 3.83M | 3.87% | $91.16M |
| Nikko asset management americas | 3.83M | 3.87% | $91.16M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Mwg management | 2.27M | 67.66% | $55.02M |
| Arch venture management | 4.54M | 22.38% | $110.19M |
| Peregrine investment management | 260.05K | 4.87% | $6.20M |
| Kynam capital management, lp | 2.52M | 4.55% | $61.10M |
| Redmile group | 1.39M | 3.28% | $33.68M |
| Casdin capital | 1.60M | 3.24% | $38.83M |
| Ark investment management | 12.13M | 2.25% | $289.14M |
| Nikko asset management americas | 3.83M | 1.29% | $91.16M |
| Farallon capital management | 10.06M | 1.00% | $244.23M |
| Iq eq fund management (ireland) | 488.42K | 0.88% | $11.64M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 7.63M | 0.00% | 928.75K |
| Qube research | 1.08M | 0.03% | 685.11K |
| Vanguard fiduciary trust | 684.87K | 0.00% | 684.87K |
| Contrarius group | 533.44K | 0.72% | 533.44K |
| State street | 4.01M | 0.00% | 370.39K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Darwin global management | - | - | -2.12M |
| Temasek (private) | - | - | -1.81M |
| Fmr | 11.69M | 0.01% | -1.27M |
| Deerfield management company, l.p. (series c) | - | - | -877.81K |
| Marshall wace, llp | 139.24K | 0.00% | -806.59K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Vanguard fiduciary trust | 684.87K | 0.00% | 684.87K | $16.32M |
| Adage capital partners gp | 175.00K | 0.01% | 175.00K | $4.25M |
| Readystate asset management lp | 93.93K | 0.10% | 93.93K | $2.28M |
| Ameriprise financial | 88.73K | 0.00% | 88.73K | $2.15B |
| Vanguard asset management | 80.70K | 0.00% | 80.70K | $1.92M |
Sold Out
| Holder | Change |
|---|---|
| Legacy wealth managment, llc/id | -4.00 |
| Global financial private client | -4.00 |
| Southstate | -5.00 |
| Ameritas advisory services | -6.00 |
| Assetmark | -8.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 75 | -67.39% | 17,407,248 | -83.67% | 16 | 0.16% | 41 | -67.20% | 20 | -61.54% |
| Sep 30, 2025 | 80 | -63.96% | 18,739,586 | -81.85% | 18 | 0.18% | 38 | -66.37% | 19 | -70.31% |
| Jun 30, 2025 | 229 | -4.98% | 108,356,461 | 8.36% | 106 | 0.82% | 117 | -17.61% | 65 | 44.44% |
| Mar 31, 2025 | 242 | 1.26% | 101,365,370 | 24.41% | 115 | 1.18% | 143 | 16.26% | 46 | -28.13% |
| Dec 31, 2024 | 237 | 3.95% | 81,473,315 | 3.08% | 98 | 1.07% | 120 | 17.65% | 65 | -1.52% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| ARK Disruptive Innovation Full Composite | 8.41M | 8.26% | -316.02K |
| ARK Innovation ETF | 6.54M | 6.36% | -477.38K |
| Fidelity Growth Compy Commingled Pl S | 4.45M | 4.32% | 86.69K |
| State Street® SPDR® S&P® Biotech ETF | 3.62M | 3.52% | -35.83K |
| Fidelity Growth Company Fund | 3.31M | 3.22% | 87.60K |
| Vanguard Total Stock Mkt Idx Inv | 3.10M | 3.04% | 204.86K |
| Nikko AM ARK Disruptive Innovation A USD | 2.92M | 2.90% | -98.23K |
| BB Biotech AG Ord | 2.89M | 2.84% | - |
| Amova ARK Disruptive Innovation A USD | 2.60M | 2.53% | -67.14K |
| Vanguard US Total Market Shares ETF | 2.33M | 2.34% | 2.59K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 01, 2026 | Evans John M. | CEO | Sell | $739.32K |
| Apr 01, 2026 | Simon Amy | Chief Medical Officer | Sell | $164.69K |
| Apr 01, 2026 | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell | $79.69K |
| Apr 01, 2026 | Bellon Christine | Chief Legal Officer | Sell | $146.40K |
| Apr 01, 2026 | Ciaramella Giuseppe | President | Sell | $290.29K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2033 Q2 | - | - |
| 2024 Q4 | - | 2 |
| 2024 Q3 | - | 3 |
| 2024 Q2 | - | 7 |
| 2024 Q1 | - | 7 |
BEAM Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools